Orkla Asa (OTCMKTS:ORKLY) Posts Quarterly Earnings Results, Hits Estimates
by Sarita Garza · The Markets DailyOrkla Asa (OTCMKTS:ORKLY – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.17 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.17, Zacks reports. Orkla Asa had a net margin of 15.69% and a return on equity of 13.83%.
Orkla Asa Stock Up 1.2%
Shares of ORKLY opened at $11.07 on Thursday. The stock’s 50-day moving average price is $10.84 and its two-hundred day moving average price is $11.82. Orkla Asa has a 12 month low of $9.91 and a 12 month high of $13.90. The company has a market capitalization of $10.91 billion, a PE ratio of 9.80 and a beta of 0.35. The company has a current ratio of 1.40, a quick ratio of 0.87 and a debt-to-equity ratio of 0.29.
Wall Street Analyst Weigh In
Separately, UBS Group lowered shares of Orkla Asa from a “hold” rating to a “strong sell” rating in a report on Friday, May 29th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce”.
Get Our Latest Analysis on Orkla Asa
About Orkla Asa
Orkla ASA (OTCMKTS: ORKLY) is a leading Norwegian industrial group with a strong focus on branded consumer goods, aluminium solutions and strategic investments. Founded in 1654 as a regional copper mine in Orkdal, Trøndelag, the company has evolved over centuries into a diversified conglomerate headquartered in Oslo. Orkla’s portfolio spans fast-moving consumer goods, including food, snacks, confectionery and personal care products, alongside advanced aluminium solutions and financial investments in select industries.
Within its branded consumer goods division, Orkla operates several business areas: Orkla Foods, Orkla Confectionery & Snacks, Orkla Care and Orkla Food Ingredients.
See Also
- Five stocks we like better than Orkla Asa
- Analog Devices’ AI Pivot Could Push Shares to Fresh Highs
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?